Literature DB >> 18456567

Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Michael Camilleri1, Sanna McKinzie, Irene Busciglio, Phillip A Low, Seth Sweetser, Duane Burton, Kari Baxter, Michael Ryks, Alan R Zinsmeister.   

Abstract

BACKGROUND & AIMS: The aim of this study was to assess pathophysiology in irritable bowel syndrome (IBS).
METHODS: A total of 122 IBS patients (3 male) and 41 healthy females underwent the following: questionnaires (symptoms, psychology), autonomic function, gut transit, gastric volumes, satiation, rectal compliance, and sensation (thresholds and pain ratings) testing. Proportions of patients with abnormal (<10th and >90th percentiles) motor or sensory functions according to bowel symptoms (constipation [C], diarrhea [D], mixed [M),) pain/bloat, and number of primary symptoms were estimated.
RESULTS: IBS subgroups (C, D, M) were similar in age, gastric and small-bowel transit, satiation, gastric volumes, rectal compliance, sensory thresholds, and pain ratings. IBS was associated with body mass index, somatic symptoms, and anxiety and depression scores. Significant associations were observed with colonic transit (IBS-C [P = .078] and IBS-D [P < .05] at 24 h; IBS-D [P < .01] and IBS-M [P = .056] at 48 h): 32% of IBS patients had abnormal colonic transit: 20.5% at 24 hours and 11.5% at 48 hours. Overall, 20.5% of IBS patients had increased sensation to distensions: hypersensitivity (<10th percentile thresholds) in 7.6%, and hyperalgesia (pain sensation ratings to distension >90th percentile for ratings in health) in 13%. Conversely, 16.5% of IBS patients had reduced rectal sensation. Pain greater than 6 times per year and bloating were not associated significantly with motor, satiation, or sensory functions. Endorsing 1 to 2 or 3 to 4 primary IBS symptoms were associated with abnormal transit and sensation in IBS.
CONCLUSIONS: In tertiary referral (predominantly female) patients with IBS, colonic transit (32%) is the most prevalent physiologic abnormality; 21% had increased and 17% had decreased rectal pain sensations. Comprehensive physiologic assessment may help optimize management in IBS.

Entities:  

Mesh:

Year:  2008        PMID: 18456567      PMCID: PMC2495078          DOI: 10.1016/j.cgh.2008.02.060

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  52 in total

1.  Mechanisms in IBS: something old, something new, something borrowed...

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

2.  Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.

Authors:  Wendy Atkinson; Stephen Lockhart; Peter J Whorwell; Brian Keevil; Lesley A Houghton
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

Review 3.  Rectal hyposensitivity.

Authors:  Marc A Gladman; Peter J Lunniss; S M Scott; Michael Swash
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

Review 4.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

5.  Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

Authors:  Bruce D Naliboff; Steve Berman; Brandall Suyenobu; Jennifer S Labus; Lin Chang; Jean Stains; Mark A Mandelkern; Emeran A Mayer
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

6.  Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.

Authors:  Simon P Dunlop; John Hebden; Eugene Campbell; Jorgen Naesdal; Lars Olbe; Alan C Perkins; Robin C Spiller
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

7.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

8.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

9.  A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

Authors:  Douglas A Drossman; Carolyn B Morris; Yuming Hu; Brenda B Toner; Nicholas Diamant; Jane Leserman; Michael Shetzline; Christine Dalton; Shrikant I Bangdiwala
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

10.  Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome.

Authors:  Simon P Dunlop; Nicholas S Coleman; Elaine Blackshaw; Alan C Perkins; Gulzar Singh; Charles A Marsden; Robin C Spiller
Journal:  Clin Gastroenterol Hepatol       Date:  2005-04       Impact factor: 11.382

View more
  85 in total

Review 1.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

2.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

3.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

4.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

5.  Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

Authors:  M Camilleri; P Carlson; S McKinzie; M Zucchelli; M D'Amato; I Busciglio; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 3.598

6.  Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-30       Impact factor: 4.052

7.  Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.

Authors:  Michael Camilleri; Eric W Klee; Andrea Shin; Paula Carlson; Ying Li; Madhusudan Grover; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-07       Impact factor: 4.052

8.  Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.

Authors:  Johanna Iturrino; Michael Camilleri; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Liver Dis       Date:  2013-10-04       Impact factor: 4.088

9.  Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans.

Authors:  Suwebatu T Odunsi; Michael Camilleri; Adil E Bharucha; Athanasios Papathanasopoulos; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2009-03-17       Impact factor: 3.199

10.  Increased risk for irritable bowel syndrome after acute diverticulitis.

Authors:  Erica Cohen; Garth Fuller; Roger Bolus; Rusha Modi; Michelle Vu; Kamyar Shahedi; Rena Shah; Mary Atia; Nicole Kurzbard; Victoria Sheen; Nikhil Agarwal; Marc Kaneshiro; Linnette Yen; Paul Hodgkins; M Haim Erder; Brennan Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-21       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.